Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant for Insomnia in MCI and Mild-to-Moderate Alzheimer's Disease
NCT05924425Phase 4Recruiting
- Sponsor
- CHU Montpellier
- Start
- Mar 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daridorexant in insomnia disorder, sponsored by CHU Montpellier. Started Mar 2024; status: recruiting.
02
Drugs
daridorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT05924425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05924425.